Literature DB >> 2088668

C7*9, a new frequent C7 allele detected by an allotype-specific monoclonal antibody.

R Würzner1, R Nitze, O Götze.   

Abstract

Two sandwich ELISA for the quantitation of C7 in human plasma--one based on a monoclonal (MAb), the other performed with a polyclonal anti-C7 IgG--were established. Results from ELISA as well as from isoelectric focussing and immunoblotting with both antibodies revealed that the MAb is directed to an allotypic epitope on C7. About 6.7% of the plasma samples did not react with this MAb. Since these findings cannot be explained by the known alleles, the existence of a new C7 allele, C7*9, was suggested, whose product C7-9 is not detected by the MAb. A gene frequency of 0.21 C7*9 was assumed. When using conventional techniques C7*9 is included in the frequency of C7*1.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2088668     DOI: 10.1159/000463163

Source DB:  PubMed          Journal:  Complement Inflamm        ISSN: 1012-8204


  7 in total

1.  Production and functional analysis of rat CD59 and chimeric CD59-Crry as active soluble proteins in Pichia pastoris.

Authors:  R J Quigg; C He; B K Hack; J J Alexander; B P Morgan
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

2.  A novel protein polymorphism of human complement C7 detected by a monoclonal antibody.

Authors:  R Würzner; M J Hobart; A Orren; K Tokunaga; R Nitze; O Götze; P J Lachmann
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

3.  Blood dendritic cells carry terminal complement complexes on their cell surface as detected by newly developed neoepitope-specific monoclonal antibodies.

Authors:  R Würzner; H Xu; A Franzke; M Schulze; J H Peters; O Götze
Journal:  Immunology       Date:  1991-09       Impact factor: 7.397

4.  Importance of the third thrombospondin repeat of C6 for terminal complement complex assembly.

Authors:  R Würzner; D Mewar; B A Fernie; M J Hobart; P J Lachmann
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

5.  C7 M/N protein polymorphism typing applied to inherited deficiencies of human complement proteins C6 and C7.

Authors:  R Würzner; N Rance; P C Potter; M L Hendricks; P J Lachmann; A Orren
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

6.  Molecular basis of subtotal complement C6 deficiency. A carboxy-terminally truncated but functionally active C6.

Authors:  R Würzner; M J Hobart; B A Fernie; D Mewar; P C Potter; A Orren; P J Lachmann
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

7.  Systemic Inflammation and Complement Activation Parameters Predict Clinical Outcome of Severe SARS-CoV-2 Infections.

Authors:  Silke Huber; Mariam Massri; Marco Grasse; Verena Fleischer; Sára Kellnerová; Verena Harpf; Ludwig Knabl; Ludwig Knabl; Tatjana Heiner; Moritz Kummann; Magdalena Neurauter; Günter Rambach; Cornelia Speth; Reinhard Würzner
Journal:  Viruses       Date:  2021-11-26       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.